days old, describing their observations as late results.
By contrast, Northway and associatcs continued after 1967 to call attention to and to make fbrther observations on the interstitial component of longer term sequelae of pressure based ventilatory support and oxygen enrichment (Northway and Rosan, 1968; Northway and Rosan, 1969; Bonikos et al., 1976; Edwards et al., 1977; Northway, 1979; Northway, 1990; Northway et al., 1990; Northway, 1992; Howling et al., 2000) . An early study of thc long tcrm radiographic findings dates from 1968. (Shepard et al., 1968) . Improvements in neonatal treatment since then have engendered rnore detailed studies of the progressive lung lesions identified in infants four to ten months old (Erickson et al., 1987) and young adult survivors (Howling et al., 2000) .
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This more recent emphasis has overshadowed early work on the first phase of the lesion complex of hyaline membrane disease, including associated interstitial and air space hemorrhage, (Shanklin and Wolfson, 1967) , and focal necrosis of terminal bronchiolar epithelium (Barter et al., 1966; Shanklin, 1971; de la Monte et al., 1986) .
Evidence is now accumulating for a genetic factor in the ability of the pulmonary interstitium to respond to either the primary pathogenesis or as an adverse factor in lung healing over time, or both, specifically mutations of the gene for ATP-binding cassette transporter protein, ABCA3 (Matsumura et al., 2006; Somaschini et al., 2007; Guala et al., 2007) . This development offers an explanation for early severe onset of pulmonary fibrosis with a high failure rate in hyaline membrane disease and led, in the index case, to the discovery of another serious developn~ental defect, in the brain. This combination of lesions, perhaps with other associated findings, has implications challenging for diagnosis, both clinical and pathological, and neonatal intensive care, and for further research at molecular, cellular, and genetic levels.
Clinical history.
Prenatal course was normal for a 30 year old primigravida until the 34th week when labor began by premature rupture of membranes. Betamethasone and penicillin G were given before the spontaneous vaginal delivery, after a total labor of 18 hours. The neonatal Apgar scores were 8 at 1 minute, 9 at 5 minutes. A female infant weighed 1770 grams. Curosurf (1 dose) and face oxygen were provided.
There was deterioration of cardioventilatory activity and she was placed on nasal CPAP, thence mechanical ventilation at 17.5 hours of life. Chest films showed hazy granular lungs with air bronchograms. Blood cultures were negative. The infant remained refractory and was transferred to -4-our NICU on the 4Ih day and placed on the oscillator. The ductus was patent with bidirectional flow by echocardiogram; there was a dilated left atrium and cardiomegaly.
Pressor support was by dopamine and dobutamine and Indocin to close the ductus (3 doses).
Antibiotics were continued. The next four days were complicated by refractory respiratory failure, persistent hyaline membrane disease, marked hypercarbia, severe acidosis, hypotension, and secondary cardiac failurc. The CRP rose >5.0 mg/dl; on the 7th day the final WBC was 6,000mm3.
On the 8th day, tension pneumothorax occurred which was treated by drainage tube. A patient management conference with family discussed the poor prognosis: the decision was made to withdraw active support, replaced by comfort care.
Placental and autopsyjindings.
The placenta1:fetal weight ratio was 0.197, a median value for 34 weeks. There was generally normal developnlent and maturation of the villi, dilation and hypertrophy of deeper vascular networks, and marginal trophoblastic hyperplasia and dccidual rcdundancy consistent with zonal placenta extrachorialis. The autopsy proper revealed: (1) unresolved somatic prematurity, (2) far advanccd active progressive pulmonary fibrosis with focal remnants of hyaline membrane formation, (3) superimposed acute bronchiolitis and pneumonia, (4) myeloid hyperplasia, marrow and myeloid metaplasia, hepatic portal triads, (5) terminal systemic leukemoid reaction, From Ambry Genetics (Aliso Viejo, CA): heterozygotic mutation of ABCA3 full gene, known mutation p.E292V, the same mutation found in case #8 of Somaschini, et al. (2007) , in 10 of 11 patients reported by Bullard, et al. (2005) but not by Matsumura, et a1.(2006) or Shulenin, et a1.(2004) .
No novel or other reported variants were identified.
Archival investigation.
Twelve cases with lung and brain findings similar to those of the index case were identified over the interval 1991-2006; four of these had many aspects in common (Table 1) 
DISCUSSION
This is a seeming case of first impression. The many conlplexities can be brought together as a condition here designated as the cerebropulmonary dysgenetic syndrome, on a provisional basis.
Information now available in the medical and genetical literature makes it possible to establish a connection between two severe pathological disorders in premature newborns:
1. Advanced and progressive pulmonary fibrosis, the late stage of hyaline membrane disease, well described as bronchopzrlrnonary &splasia. The link between these seemingly disparate devastations of key tissues in the newborn infant lies with the demonstration of a ABCA3 heterozygotic mutant status in this case. ABCA3 is one mcmber of the ATP-binding casette transporter family A3, an important group of substance transport nlolecules (Dean et al., 2001) . Mutations in the ABCA3 gene have been identified as a principal factor in fatal neonatal surfactant dcficicncy (Shulcnin et al., 2004; Bullard et al., 2005) .
Maturational discordance in the central
Moreover, the ABCA3 mutants have been well characterized, classified, and localized in type 2 pneumocytes which produce surfactant, (Matsumura et al., 2006) , thus setting the cellular stage for the depletion of stored surfactant following the challenge of initial lung expansion (Bolande and Klaus, 1964) , with an inability to replenish the surfactant. In addition, LBM180, a lamellar body limiting membrane protein of type 2 pneumocytes, has been identified as ABCA3 trailsporterprotein The link between the pulmonary disorder and the abnormal brain lies in some exacting work on the brain of the developing mouse which establishes an abundance of the ABCA3 protein in cortical mantle (Tachikawa et al., 2005) , sometimes referred to in the fetal mouse as the differentiating zone. ABCA3 is also found throughout the early brain, but is not upregulated post natally in the white matter after the migration is completed (Tachikawa et al., 2005) .
The superfanlily of human ABC genes is complex with expression ofABCA3 in lung and that of ABCA2 in brain (Dean et al., 2001 ). ABCA2 and ABCA3 are closely related in subgroup ABCA-I (Dean et al., 2001) . The ABCA3 sequence is highly conserved in humans, rats, and mice in the region of the E292V mutation (Bullard et al., 2005) , enhancing the validity of applying the results ofTachikawa, et a1 (2005) in mice to the scope of disorders here described as the cerebropulmonary dysgenetic syndrome.
We have observed the unusual fibrous trabeculation of the thyroid occasionally but not systematically. Abnormal thyroid developn~ent and poor function were described in instances of global cerebral malformation by Shanklin (1991) , offering the possibility of more than one factor at work in the endocrinopathy seen in our index case and in several from archival review.
The genetic mutation behind this pathogenesis has been attributed to an autosoma1 recessive state in a study on 12 newborns (Guala, et al., 2007) . By contrast, another report of similar size , identified three of 14 as heterozygotic mutants [their patients 7, 8, and 131. Bullard, et al. (2005) , described three older individuals (ages 11, 16, and 23 years) with the same missence mutation, E292V, found in our index patient, with a second mutation. These three patients has interstitial lung disease at their much later stage of life (Bullard, et al., 2005) . These seeming discrepancies are evidence for compounded or multifactorial pathogenesis which may include such counterintuitive results as an autosoma1 dominant variant of the Wiskott-Aldrich syndrome, classically understood to be an X-linked recessive disease (Rocca, et al., 1996) . It may be that certain regulatory proteins have to present in both parental genomes for proper function in the offspring. A variant allele through mutation can be sufficient to create an abnormal phenotype in that the haploid state of the wild type allele is inadequate for normal function. This is the case for a number of disorders. Women with heterozygous a-galactosidase mutations (Fabry disease) suffer from significant multisystemic disease, resulting in a reduced quality of life (Wang, et a] ., 2007).
Wang and associates studied 44 heterozygous women, a majority referred due to an affected male relative, of whom about 75% reported acroparesthesias as their first symptom .
Other symptoms were prominent such as fatigue with reduced oxygen consumption, exercise intolerance with low heart rate during exercise testing, and angina, symptoms charactcristic of thc homozygous state . Comparable confounding heterozygotic abnormalities have been described for familial hypobetalipoproteinemia (Alapont Puchalt, et al., 2004) . Perhaps the best example of enhanced risk for disease manifestations from the heterozygous mutant state is factor V Lcidcn (Glucck, et al., 2007; Herman, et al., 2006; In~perialc, ct al., 2007; Kalajian, et al., 2007; Marchiori, et al., 2007; Verdu, et al., 2005) . Marchiori, et al. (2007) estimated risk ratios on the order of 1.39 to 1.45, which, considcring the tendency for this trait to bccomc manifcst in -10-pregnancy, is an important health problem. At a fundamental cellular lcvcl, DNA polymerase P, carries out base excision repair necessary for DNA maintenance (Bhattacharyya and Banerjee, 1997) . A variant polymerase from deletion in the 87-bp region, in the heterozygous state, results in cells incapable of base excision repair and highly sensitive to the known group 2A animal carcinogen, N-methyl-N'-nitro-N-nitrosoguanidine (Bhattacharyya and Banerjee, 1997; Fujii and Nakadate, 1977) .
The index case in this report serves to suggest more frcqucnt gcnctic testing in the clinical scenario of early bronchopulmonary dysplasia in premature newborns will provide necessary data by -which to assess the prevalence of this potential complication of neonatal care. The archival cases reported here are a window onto new aspects of developn~ent of the human fetal brain. There are now four well documented examples of severe bronchopulmonary dysplasia related to heterozygous mutations in the ABCA3 transporter protein gene (Somaschini, et al., 2007 and this casc) . The existence of an increasing number of instances where the heterozygous state carries significant risk burdens (as cited above) is a compelling argument for further study and clarification of the risk and the processes by which these disorders are manifested.
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